Colchicine in atrial fibrillation: are old trees in bloom?

Yujia Zhan; Honghua Yue; Xueshan Zhao; Juan Tang; Juan Tang; Zhong Wu

doi:10.3389/fphys.2023.1260774

Frontiers in Physiology (Oct 2023)

Colchicine in atrial fibrillation: are old trees in bloom?

Yujia Zhan,
Honghua Yue,
Xueshan Zhao,
Juan Tang,
Juan Tang,
Zhong Wu

Affiliations

Yujia Zhan: Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China
Honghua Yue: Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China
Xueshan Zhao: Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China
Juan Tang: Acupuncture and Moxibustion School of Teaching, Hospital of Chengdu, University of Traditional Chinese Medicine, Tianjin, China
Juan Tang: Key Laboratory of Emergency and Trauma, Ministry of Education, Hainan Medical University, Haikou, China
Zhong Wu: Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China

DOI: https://doi.org/10.3389/fphys.2023.1260774
Journal volume & issue: Vol. 14

Abstract

Read online

Colchicine is a widely used drug that was originally used to treat gout and rheumatic diseases. In recent years, colchicine has shown high potential in the cardiovascular field. Atrial fibrillation (AF) is a cardiovascular disease with a high incidence. One of the most frequent complications following cardiovascular surgery is postoperative atrial fibrillation (POAF), which affects patient health and disease burden. This article reviews the research status of colchicine in AF and summarizes the relevant progress.

Published in Frontiers in Physiology

ISSN: 1664-042X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Science: Physiology
Website: https://www.frontiersin.org/journals/physiology

About the journal

Abstract

Keywords